PlexusDx supports this precision approach by offering both genetic predisposition context and guidance on which compounded GLP-1 options (semaglutide, tirzepatide, or microdose protocols) may align with your personalized risk-benefit profile and budget
Anyone with a bleeding disorder, anyone taking anticoagulants, and anyone with anatomical variations should discuss site selection before starting therapy
(PubMed) Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A, 3rd
R., Adachi, N
Menstrual cycle changes are not listed as a known adverse effect in the MHRA-approved Summary of Product Characteristics
Current side effects : Report any ongoing symptoms, particularly nausea, vomiting, diarrhoea, dizziness, or fatigue